Ultraviolet radiation-induced tolerance

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 54, Issue 12, 1999, Pages 1252-1261

  Schwarz, Thomas ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FLUORESCEIN ISOTHIOCYANATE; HAPTEN; INTERLEUKIN 12; TUMOR NECROSIS FACTOR; UROCANIC ACID;

APOPTOSIS; CONTACT ALLERGY; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; ULTRAVIOLET RADIATION;

ANIMALS; DERMATITIS, CONTACT; HUMANS; IMMUNE TOLERANCE; ULTRAVIOLET RAYS;

EID: 0033370680     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.1999.00105.x     Document Type: Review

References (90)

1. 1. Fisher GJ, Wang ZQ, Datta SC, Varani J, Kang S, Voorhees JJ. Pathophysiology of premature skin aging induced by ultraviolet light. N Engl J Med 1997;373:1419-1428.
2. 2. Gilchrest BA. Actinic injury. Annu Rev Med 1990;41:199-210.
3. 3. Kraemer KH. Sunlight and skin cancer: another link revealed. Proc Natl Acad Sci U S A 1997;94:11-14.
4. 4. Young AR. The sunburn cell. Photodermatology 1987;4:127-134.
5. 5. Kripke ML. Antigenicity of murine skin tumors induced by ultraviolet light. J Natl Cancer Inst 1974;53:1333-1336.
6. 6. Kripke ML. Latency, histology and antigenicity of tumors induced by ultraviolet light in three inbred mouse strains. Cancer Res 1977;37:1395-1400.
7. 7. Kripke ML. Effects of UV radiation on tumor immunity. J Natl Cancer Inst 1990;82:1392-1396.
8. 8. Kripke ML, Lofgreen JS, Beard J, Jessup JM, Fisher MS. In vivo immune responses of mice during carcinogenesis by ultraviolet irradiation. J Natl Cancer Inst 1977;59:1227-1230.
9. 9. Fisher MS, Kripke ML. Systemic alteration induced in mice by ultraviolet light irradiation and its relationship to ultraviolet carcinogenesis. Proc Natl Acad Sci U S A 1977;74:1688-1692.
10. 10. DeFabo EC, Kripke ML. Dose-response characteristics of immunologic unresponsiveness to UV-induced tumors produced by UV irradiation of mice. Photochem Photobiol 1979;30:385-390.
11. 11. Spellman CW, Woodward JG, Daynes RA. Modification of immunological potential by ultraviolet radiation. I. Immune status of short-term UV-irradiated mice. Transplantation 1977;24:112-119.
12. 12. Spellman CW, Daynes RA. Modification of immunological potential by ultraviolet radiation. II. Generation of suppressor cells in short-term UV-irradiated mice. Transplantation 1997;24:120-126.
13. 13. Kripke ML, Thorn RM, Lill PH, Civin PI, Pazmino NH, Fisher MS. Further characterization of immunological unresponsiveness induced in mice by ultraviolet radiation. Growth and induction of nonultraviolet-induced tumors in ultraviolet-irradiated mice. Transplantation 1979;28:212-217.
14. 14. Spellman CW, Daynes RA. Cross-reactive transplantation antigens between UV-irradiated skin and UV-induced tumors. Photodermatology 1984;1:164-169.
15. 15. Roberts LK, Lynch DH, Daynes RA. Evidence for two functionally distinct cross-reactive tumor antigens associated with ultraviolet light and chemically induced tumors. Transplantation 1982;33:352-360.
16. 16. Hostetler LW, Romerdahl CA, Kripke ML. Specificity of antigens on UV radiation-induced antigenic tumor cell variants measured in vitro and in vivo. Cancer Res 1989;49:1207-1213.
17. 17. Roberts LK, Spellman CW, Warner NL. Establishment of a continuous T cell line capable of suppressing anti-tumor immune responses in vivo. J Immunol 1983;131:514-519.
18. 18. Roberts LK, Samlowski WE, Daynes RA. Immunological consequences of ultraviolet radiation exposure. Photodermatology 1986;3:284-298.
19. 19. Ullrich SE, Kripke ML. Mechanisms in the suppression of tumor rejection produced in mice by repeated UV irradiation. J Immunol 1984;133:2786-2790.
20. 20. Toews GB, Bergstresser PR, Streilein JW. Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB. J Immunol 1980;124:445-453.
21. 21. Aberer W, Schuler G, Stingl G, Höngismann H, Wolff K. Ultraviolet light depletes surface markers of Langerhans cells. J Invest Dermatol 1981;76:202-210.
22. 22. Streilein JW, Bergstresser PR. Genetic basis of ultraviolet-B effects on contact hypersensitivity. Immunogenetics 1988;27:252-258.
23. 23. Streilein JW, Taylor JR, Vincek V, et al. Immune surveillance and sunlight-induced skin cancer. Immunol Today 1994,15:174-179.
24. 24. Yoshikawa T, Streilein JW. Genetic basis of the effects of ultraviolet light B on cutaneous immunity. Evidence that polymorphism at the TNF-α and Lps loci governs susceptibility. Immunogenetics 1990;32:398-405.
25. 25. Noonan FP, DeFabo EC. Ultraviolet-B dose-response curves for local and systemic immunosuppression are identical. Photochem Photobiol 1990;52:801-808.
26. 26. Yamawaki M, Katiyar SK, Anderson CY, Tubesing KA, Mukhtar H, Elmets CA. Genetic variation in low-dose UV-induced suppression of contact hypersensitivity and in the skin photocarcinogenesis response. J Invest Dermatol 1998;111:706-708.
27. 27. Noonan FP, DeFabo EC, Kripke ML. Suppression of contact hypersensitivity by UV radiation: an experimental model. Springer Semin Immunopathol 1981;4:293-304.
28. 28. Yoshikawa T, Rae V, Bruins-Slot W, van den Berg J-W, Taylor JR, Streilein JW. Susceptibility to effects of UVB radiation on induction of contact hypersensitivity as a risk factor for skin cancer in humans. J Invest Dermatol 1990;95:530-536.
29. + epidermal macrophage induction, and Langerhans cell depletion. Proc Natl Acad Sci U S A 1992;89:8497-8501.
30. + cells that enhance epidermal alloantigen presentation. J Immunol 1985;134:129-137.
31. + melanophages appear in human epidermis after ultraviolet radiation. J Invest Dermatol 1986;86:363-370.
32. + suppressor/cytotoxic lymphocytes. J Immunol 1988;140:1738-1744.
33. + suppressor-inducer T cells. J Immunol 1990;145:2854-2861.
34. + macrophages that infiltrate human epidermis after in vivo ultraviolet exposure potently produce IL-10 and represent the major secretory source of epidermal IL-10 protein. J Immunol 1994;153:5256-5264.
35. 35. Stevens SR, Shibaki A, Meunier L, Cooper KD. Suppressor T cell-activating macrophages in ultraviolet-irradiated human skin induce a novel, TGF-beta-dependent form of T cell activation characterized by deficient IL-2r alpha expression. J Immunol 1995;155:5601-5607.
36. 36. Elmets CA, Bergstresser PR, Tigelaar RE, Wood PJ, Streilein JW. Analysis of the mechanism of unresponsiveness produced by haptens painted on skin exposed to low dose ultraviolet radiation. J Exp Med 1983;158:781-794.
37. 37. Noonan FP, DeFabo EC, Kripke ML. Suppression of contact hypersensitivity by UV radiation and its relationship to UV-induced suppression of tumor immunity. Photochem Photobiol 1981;34:683-689.
38. 38. Ullrich SE, McIntryre WB, Rivas JM. Suppression of the immune response to alloantigen by factors released from ultraviolet-irradiated keratinocytes. J Immunol 1990:145:489-498.
39. + T cells. J Invest Dermatol 1998;110:272-276.
40. 40. Glass MJ, Bergstresser PR, Tigelaar RE, Streilein JW. UVB radiation and DNFB skin painting induce suppressor cells universally in mice. J Invest Dermatol 1990;94:273-278.
41. 41. Saijo C, Bucana CD, Ramirez KM, Cox PA, Kripke ML, Strickland FM. Deficient antigen presentation and Ts induction are separate effects of ultraviolet irradiation. Cell Immunol 1995;164:189-202.
42. 42. Shreedar VK, Pride MW, Sun Y, Kripke ML, Strickland FM. Origin and characteristics of ultraviolet-B radiation-induced suppressor T lymphocytes. J Immunol 1998;161:1327-1335.
43. 43. Stingl G, Shevach EM. Langerhans cells as antigen-presenting cells. In: Schuler G, editor. Epidermal Langerhans cells. Boca Raton, FL: CRC Press, 1991:159-190.
44. 44. Schuler G, Steinman RM. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J Exp Med 1985;161:526-546.
45. 45. Morison WL, Bucana C, Kripke ML. Systemic suppression of contact hypersensitivity by UVB radiation is unrelated to the UVB-induced alterations in the morphology and number of Langerhans cells. Immunology 1984;52:299-306.
46. 46. Vermeer M, Streilein JW. Ultraviolet B light-induced alterations in epidermal Langerhans cells are mediated in part by tumor necrosis factor-alpha. Photodermatol Photoimmunol Photomed 1990;7:258-265.
47. 47. Shimizu T, Streilein JW. Local and systemic consequences of acute, low-dose ultraviolet B radiation are mediated by different immune regulatory mechanisms. Eur J Immunol 1994;24:1765-1770.
48. 48. Shimizu T, Streilein JW. Evidence that ultraviolet B radiation induces tolerance and impairs induction of contact hypersensitivity by different mechanisms. Immunology 1994;82:140-148.
49. bright monocytic/macrophagic cells. J Immunol 1994;153:4915-4924.
50. 50. Hammerberg C, Duraiswamy N, Cooper KD. Reversal of immunosuppression inducible through ultraviolet-exposed skin by in vivo anti-CD11b treatment. J Immunol 1996;157:5254-5261.
51. 51. Hammerberg C, Katiyar SK, Carroll M, Cooper KD. Activated complement component 3 (C3) is required for ultraviolet induction of immunosuppression and antigenic tolerance. J Exp Med 1998;187:1133-1138.
52. 52. Schwarz T, Urbanski A, Luger TA. Ultraviolet light and epidermal cell derived cytokines. In: Luger TA, Schwarz T, editors. Epidermal growth factors and cytokines. New York: Marcel Dekker, 1994:303-363.
53. 53. Schwarz T, Urbanska A, Gschnait F, Luger TA. Inhibition of the induction of contact hypersensitivity by a UV-mediated epidermal cytokine. J Invest Dermatol 1986;87:289-291.
54. 54. Kim TY, Kripke ML, Ullrich SE. Immunosuppression by factors released from UV-irradiated epidermal cells: selective effects on the generation of contact and delayed hypersensitivity after exposure to UVA or UVB radiation. J Invest Dermatol 1990:94:26-32.
55. 55. Swartz RP. Role of UVB-induced serum factor(s) in suppression of contact hypersensitivity in mice. J Invest Dermatol 1984;83:305-307.
56. 56. Christensen OB, Christensen MB, Wall LM. UVB serum factor: suppression of allergic contact dermatitis in guinea pigs. Contact Dermatitis 1987;16:208-211.
57. 57. Kurimoto I, Streilein JW. Deleterious effects of cis-urocanic acid and UVB radiation on Langerhans cells and on induction of contact hypersensitivity are mediated by tumor necrosis factor alpha. J Invest Dermatol 1992;99:69S-70S.
58. 58. Enk AH, Angeloni VL, Udey MC, Katz SI. Inhibition of Langerhans' cell antigen-presenting function by IL-10. A role for IL-10 in tolerance induction. J Immunol 1993;151:2390-2398.
59. 59. Enk AH, Katz SI. Identification and induction of keratinocyte-derived IL-10. J Immunol 1992;149:92-95.
60. 60. Rivas JM, Ullrich SE. Systemic suppression of DTH by supernatants from UV-irradiated keratinocytes: an essential role for IL-10. J Immunol 1992;148:3133-3139.
61. 61. Enk AH, Katz SI. Early molecular events in the induction phase of contact sensitivity. Proc Natl Acad Sci U S A 1992;89:1398-1402.
62. 62. Enk AH, Saloga J, Becker D, Mohamadzadeh M, Knop J. Induction of hapten-specific tolerance by interleukin-10 in vivo. J Exp Med 1994:179:1397-1402.
63. 63. Ullrich SE. Mechanisms involved in the systemic suppression of antigen-presenting cell function by UV irradiation. Keratinocyte-derived IL-10 modulates antigen-presenting cell function of splenic adherent cells. J Immunol 1994;152:3410-3416.
64. 64. Schwarz A, Grabbe S, Riemann H, et al. In vivo effects of interleukin-10 on contact hypersensitivity and delayed type hypersensitivity reactions. J Invest Dermatol 1994;103:211-216.
65. 65. Shreedar V, Giese T, Sung VW, Ullrich SE. A cytokine cascade including prostaglandin E2, IL-4, and IL-10 is responsible for UV-induced systemic immune suppression. J Immunol 1998:160:3783-3789.
66. 66. Niizeki H, Streilein JW. Hapten-specific tolerance induced by acute, low-dose ultraviolet B radiation of skin is mediated via interleukin-10. J Invest Dermatol 1997;109:25-30.
67. 67. Mohammad T, Morrison H, Hogen Esch H. Urocanic acid photochemistry and photobiology. Photochem Photobiol 1999;69:115-135.
68. 68. DeFabo EC, Noonan FP. Mechanism of immune suppression by ultraviolet irradiation in vivo. I. Evidence for the existence of a unique photoreceptor in skin and its role in photoimmunology. J Exp Med 1983;158:84-89.
69. 69. Moodycliffe AM, Norval M, Kimber I, Simpson TJ. Characterization of a monoclonal antibody to cis-urocanic acid: detection of cis-urocanic acid in the serum of irradiated mice by immunoassay. Immunology 1993;79:265-275.
70. 70. Trinchieri G. Interleukin-12 and its role in the generation of Th1 cells. Immunol Today 1993;14:335-338.
71. 71. Hauser C. Cultured epidermal Langerhans cells activate effector T cells for contact sensitivity. J Invest Dermatol 1990;95:436-440.
72. 72. Riemann H, Schwarz A, Grabbe S, et al. Neutralization of interleukin-12 in vivo prevents induction of contact hypersensitivity and induces hapten specific tolerance. J Immunol 1996;156:1799-1803.
73. 73. Müller G, Saloga J, Germann T, Schuler G, Knop J, Enk AH. IL-12 as mediator and adjuvant for the induction of contact sensitivity in vivo. J Immunol 1995;155:4661-4668.
74. 74. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G. Interleukin 10 inhibits human lymphocyte interferon gamma production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 1993;178:1041-1048.
75. 75. Kubin M, Kamoun M, Trinchieri G. Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells. J Exp Med 1994;180:211-222.
76. 76. Schmitt DA, Owen-Schaub L, Ullrich SE. Effect of IL-12 on immune suppression and suppressor cell induction by ultraviolet radiation. J Immunol 1995;154:5114-5120.
77. 77. Schwarz A, Grabbe S, Aragane Y, et al. Interleukin-12 prevents UVB-induced local immunosuppression and overcomes UVB-induced tolerance. J Invest Dermatol 1996;106:1187-1191.
78. 78. Lynch DH, Ramsdell F, Alderson MR. Fas and FasL in the homcostatic regulation of immune responses. Immunol Today 1995;16:569-574.
79. 79. Itoh M, Yonehara S, Ishii A, et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991;66:233-243.
80. 80. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993;75:1169-1178.
81. 81. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC. A role for Fas ligand in preventing graft rejection. Nature 1995;377:630-632.
82. 82. Hahne M, Rimoldi D, Schröter M, et al. Melanoma cell expression of Fas (APO-1/CD95) ligand: implications for tumor immune escape. Science 1996;274:1363-1366.
83. 83. Schwarz A, Grabbe S, Grosse-Heitmeyer K, et al. Ultraviolet light induced immune tolerance is mediated via the CD95/CD95-ligand system. J Immunol 1998;160:4262-4270.
84. 84. Takahashi T, Tanaka M, Brannan CI, et al. Generalized lymphoproliferative disease in mice caused by a point mutation in the Fas ligand. Cell 1994;76:969-976.
85. 85. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992;356:314-317.
86. 86. Hill LL, Shreedar VK, Kripke ML, Owen-Schaub LB. A critical role for Fas ligand in the active suppression of systemic immune responses by ultraviolet radiation. J Exp Med 1999;189:1285-1293.
87. 87. Grabbe S, Schwarz T. Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol Today 1998;19:37-43.
88. 88. MacDonald. T cell immunity to oral allergens. Curr Opin Immunol 1998;10:620-627.
89. 89. Miller JF, Kurts C, Allison J, Kosaka H, Carbone F, Heath WR. Induction of peripheral CD8 + T-cell tolerance by cross-presentation of self antigens, Immunol Rev 1998;165:267-277.
90. + T helper type 2 cells. J Exp Med 1996;183:759-768.